Marshall Wace’s iHuman IH Stock Holding History

Marshall Wace’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,660	Closed	-$203K	–	3207
2021 Q2	$203K	Buy	+19,660	New	+$217K	﹤0.01%	2438

Other funds holding IH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Marshall Wace's IH Position: Q3 2021 in Review

Marshall Wace sold out of iHuman (IH) in Q3 2021, closing a stake of 19,660 shares — an estimated $203K sold.

Marshall Wace first reported a position in IH in Q2 2021 and held it in 1 quarter. The position peaked at $203K in Q2 2021. 10 funds tracked by Wall St. Rank hold IH as of Q3 2021.

Marshall Wace reported no remaining iHuman position as of Q3 2021 after selling out during the quarter.
Marshall Wace sold 19,660 iHuman shares in Q3 2021, an estimated $203K.
Marshall Wace first reported a position in iHuman in Q2 2021 and held it in 1 quarter.
Marshall Wace's iHuman position peaked at $203K in Q2 2021.
10 funds tracked by Wall St. Rank held iHuman as of Q3 2021.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.